CHARLOTTE, NC – (BUSINESS THREAD) – cbdMD, Inc. (NYSE American: YCBD, YCBDpA), one of the leading, most trusted and recognized CBD companies, today announced its exclusive multi-year deal with Amify, an Amazon.com, Inc. (NASDAQ). : AMZN), partner of the platform, to prepare for the inclusion of CBD products in the Amazon market. Amify, which specializes in Amazon’s outreach, content creation and operational excellence strategies, will act as cbdMD’s exclusive CBD partner to launch products on the Amazon platform as soon as the category is accepted and available. This partnership includes all of cbdMD’s leading and award-winning cbdMD products, including cbdMD jelly beans, tinctures, gelcaps and clichés, as well as the award-winning animal brand Paw CBD. In addition, the new line of beauty and skin care products under the cbdMD Botanicals brand will also be available.
Interest in making CBD more available has grown exponentially since the passage of the Farm Bill in 2018, and cbdMD believes that Amazon is expected to become a major platform for distributing CBD products. In preparation for the inclusion of the category, cbdMD has worked with Amify to create central vendor accounts, create product pages, and other essential components of the cbdMD Amazon Store, and has established Amazon launch strategies for to make full use of the Amazon platform. In addition to assisting brands in effective marketing of brands and products with their award-winning advertising and content, Amify also works to manage storefronts, monitor inventory and demand planning, and manage customer service and returns. with an expert internal team. Amify refers to its unique approach as an Amazon-as-a-Service provider. The company is responsible for creating, developing, and executing effective Amazon personalized strategies that align with broader e-commerce sales and goals. With this exclusive partnership, cbdMD is ready to fully integrate its digital marketing, content healing and product innovation with the world’s largest online retailer.
“As an industry, this is the moment we have all been waiting for and we believe we are close. When a global retailer like Amazon is ready to accept your products, prepare and refine your strategy so that it is ready to hit the market as soon as possible. This is exactly what this association represents. We are already one of the largest online CBD companies in America, and this distribution channel will play into our strength. We are delighted to be at the forefront of including this category and are taking all the necessary steps to properly prepare for the launch. As long as it’s the launch, we’ll be ready, ”said president and co-CEO Martin Sumichrast.
About Amify
Amify offers award-winning, turnkey services to help brands continually launch, manage and optimize their Amazon channel strategy. As Amazon’s premier service provider, we serve as an outsourced Amazon team, helping companies own their brand on the world’s largest e-commerce platform by leveraging cross-channel data to increase sales and improve the customer experience. The Amify team brings extensive experience to marketers, from branding and advertising to data analytics and business operations. From our beautiful high-performance storefronts to our optimized forecasting and logistics, we are an integrated extension of our customer’s team, whose mission is to make customers win on Amazon without pain. Visit GoAmify.com for more information on their full service offerings.
About cbdMD, Inc.
cbdMD, Inc. is one of the leading and most trusted and recognized cannabidiol (CBD) brands with a full line of THC1-free CBD products produced in the United States. Our cbdMD brand currently includes over 130 SKUs of high quality CBD products, including CBD tinctures, CBD jelly beans, CBD topicals, CBD capsules, CBD bath pumps, CBD bath salts, sleeping pills CBD and CBD beverage blends. Our Paw CBD pet product brand includes over 45 SKUs of veterinary formulated products, including tinctures, chews, topical products in different concentrations, and our cbdMD Botanicals skin care and beauty product brand includes 15 SKUs , which include facial oil and serum, toners. , moisturizers, fair skin, face masks, scrubs and body care. The company also offers a full spectrum product line (approximately 10 SKUs) under its cbdMD brand. For more information on cbdMD and its extensive line of CBC-free, THC1-free CBD oil products, visit www.cbdmd.com, follow cbdMD on Instagram and Facebook, or visit one of the 6,000 outlets offering cbdMD products .
Prospective statements
This press release contains certain forward-looking statements that are based on current expectations and involve certain risks and uncertainties within the meaning of the US Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified by using for words such as ” should ”, ” may, ” ” intend ”, ” anticipate ”, ” believe ”, ” estimate ”, ” projects, ” ” forecasts, ” ” wait ”, ” plan ” and ” propose ”. These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, some of which are beyond our control and are difficult to predict. and could cause actual results to differ materially from those expressed or anticipated in the forward-looking statements, including, without limitation, statements made regarding the expansion of the consumer market for CBD products, our ability to increase our share market, the availability of the Amazon platform for our CBD products, our ability to expand our business and significantly increase our revenue, our ability to effectively leverage our brand partnerships and sponsorships, our ability to compete effectively in our market, our ability to achieve our net sales guidance and our ability to report profitable operations in the future. . We urge you to carefully review and consider any warnings and other disclosures, including statements made under the heading “Risk Factors” in the cbdMD, Inc. Annual Report. on Form 10-K for the fiscal year ended September 30, 2020 as filed with the Securities and Exchange Commission (the “SEC”) and our other filings with the SEC. All forward-looking statements involve significant risks and uncertainties that could cause actual results to differ materially from those of forward-looking statements, many of which are generally beyond the control of cbdMD, Inc. and are difficult to predict. cbdMD, Inc. assumes no obligation to update any forward-looking statements unless required by law. The information on our websites and social media platforms, including Instagram and Facebook, is not part of this press release.
Without 1THC it is defined as below the level of detection by validated scientific methods.
No related posts.
